METHOD FOR DETECTING RISK OF TORSADES DE POINTES

1 . A method for estimating or detecting the risk for a patient to have a torsade de pointes event,

wherein the method for estimating the risk comprises:

a. receiving, by a processing device, signal data representing a time segment of an ECG waveform of a subject patient; and

b. analyzing, by the processing device via a configured artificial machine learning classifier, said signal data to generate likelihoods as output of the artificial neural network, wherein the likelihoods relate to the risk for the patient to have a torsade de pointes event; and

wherein the method for detecting the risk comprises:

a. obtaining ECG data from the patient;

b. applying the ECG data to a machine learning classifier configured to detect variations in the ECG data indicative of a risk for the patient to have a torsade de pointe event; and

c. obtaining an output from the machine learning classifier, wherein the output provides a likelihood of the risk for the patient to have a torsade de pointe event.

2 . (canceled)

3 . The method of claim 1 , wherein the ECG data in the method for detecting the risk is sent to a remote machine learning classifier and wherein the output is sent to the patient and/or to a physician.

4 . The method of claim 1 , wherein the patient has a risk of having a torsade de pointes event within 48 hours.

5 . The method of claim 1 , wherein the patient has a risk of having a torsade de pointes event within 24 hours.

6 . A method for producing a machine learning classifier capable of estimating the risk for a patient to have a torsade de pointes event, and underlying mechanism thereof, comprising

a. storing in an electronic database patient data comprising a first parameter that is ECG from the patient, a second parameter relating to the risk for the patient to have a torsade de pointe event, and a third parameter relating to the cause thereof;

b. providing a machine learning system; and

c. training the machine learning system using the patient data, such that the machine learning system is trained to produce a prediction on the risk for the patient to have a torsade de pointe event and cause thereof when exposed to an ECG from a patient.

7 . The method of claim 6 , wherein the machine learning classifier is an artificial neural network capable of estimating the risk for a patient to have a torsade de pointes event, and cause thereof, wherein:

step b. comprises providing a network of nodes interconnected to form an artificial neural network, the nodes comprising a plurality of artificial neurons, each artificial neuron having at least one input with an associated weight; and

step c. comprises training the artificial neural network using the patient data such that the associated weight of the at least one input of each artificial neuron of the plurality of artificial neurons is adjusted in response to respective first, second and third parameters of a plurality of different sets of data from the patient data, such that the artificial neural network is trained to produce a prediction on the risk for the patient to have a torsade de pointe event and cause thereof when exposed to an ECG from a patient.

8 . The method of claim 6 , wherein the patient data comprises ECG from patients having been administered a QT-prolonging drug and ECG from patients not having been administered a QT-prolonging drug.

9 . The method of claim 1 , which is used for determining the risk for a substance to induce a torsadogenic effect after administration to a patient, and comprises:

a. obtaining ECG data from the patient after administration of said composition;

b. applying the ECG data to a machine learning classifier configured to detect variations in the ECG data indicative of increased risk of torsade de pointes event; and

c. obtaining an output from the machine learning classifier, wherein the output provides a risk for the patient to have a torsade de pointe event,

wherein the substance presents a risk of induction of a torsadogenic effect if a risk for the patient to have a torsade de pointe event is obtained after administration of the substance.

10 . The method of claim 9 , which is repeated on a cohort of patients greater than or equal to 10.

11 . A method for determining the nature of a congenital Long QT syndrome in a patient, comprising:

a. obtaining ECG data from the patient;

b. applying the ECG data to a machine learning classifier configured to detect variations in the ECG data indicative of the risk of torsade de pointes event;

c. obtaining an output from the machine learning classifier, wherein the output provides a likelihood of the nature of the long QT and whether the congenital Long QT syndrome is a LQT2 syndrome or a LQT1 or LQT3 syndrome.

12 . The method of claim 1 , wherein the machine-learning classifier is a neural network.

13 . The method of any one of claim 1 , wherein the patient is assigned to a class by

a. repeating the methods with different ECG signals from the same patient and

b. assigning the patient in the class for which the majority of the outputs indicate the highest probability.

14 . The method of claim 1 , wherein the patient is assigned to a class by

a. repeating the methods with ECG signals from the patient using different machine learning classifiers obtained according to the method of claim 3 or 4 and

b. assigning the patient in the class for which the majority of the outputs indicate the highest probability.

15 . The method of claim 1 , wherein the ECG signal is an ECG signal from one single lead.

16 . The method of claim 1 , wherein the ECG signal is an ECG signal from more than one lead.

17 . (canceled)

18 . (canceled)

19 . The method of claim 6 , wherein the machine-learning classifier is a neural network.

20 . The method of claim 11 , wherein the machine-learning classifier is a neural network.

21 . The method of claim 6 , wherein the ECG signal is an ECG signal from one single lead.

22 . The method of claim 6 , wherein the ECG signal is an ECG signal from more than one lead.